InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: flipper44 post# 86944

Wednesday, 12/07/2016 2:13:28 PM

Wednesday, December 07, 2016 2:13:28 PM

Post# of 696789
Great post Flip and agree with you on the pricing as Linda has mentioned a couple of times a while back the annual cost of DCVax at $37k per year or $111k for 3 year manufacturing of each patients vaccine of DCVax!

LP did three television interviews in one day back in May 2013 explaining why DCVax-L could lower cancer therapy prices. Here is one.



DCVax-L should ultimately lower costs of U.S healthcare dramatically if it is approved. IMHO

Quote:
Trump’s presidential transition website makes no mention of too-high drug prices, though it does say the new administration will “reform the Food and Drug Administration to put greater focus on the need of patients for new and innovative medical products.” -- Monarch


Put that together with Trump's statements today that he will lower drug care prices, and NWBO has an advantage since it can (may) enter a commercial environment where it shines as the poster child for a new and innovative economical cancer therapy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News